Concluding Remarks and Future Directions
Part of the
Advances in Experimental Medicine and Biology
book series (AEMB, volume 34)
The organizers and sponsors are to be commended for assembling this high quality, exciting, and enjoyable symposium: the third in a series of scientific interchanges spanning various aspects of hematopoiesis. Drs. Nader G. Abraham, Joao Ascensao, Mehdi Tavassoli, Esmail Zanjani, and especially Richard D. Levere and the Department of Medicine, New York Medical College deserve special recognition for this successful event to commemorate the 100th Anniversary of the National Institutes of Health.
KeywordsAplastic Anemia Recombinant Human Erythropoietin Hematopoietic Growth Factor Fetal Hemoglobin Blood Disease
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Eschbach, J.W., J.C. Egrie, M.R. Downing, J.K. Browne, and J.W. Adamson. 1987. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N. Engl. J. Med.
316s 73–78.PubMedCrossRefGoogle Scholar
Groopman, J.E., R.T. Mitsuyasu, M.J. DeLeo, D.H. Oette, and D.W. Golde. 1987. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N. Engl. J. Med.
317: 593–598.PubMedCrossRefGoogle Scholar
Al-Khatti, A., R.W. Veith, T. Papayannopoulou, E.F. Fritsch, E. Goldwasser, and G. Stamatoyannopoulos. 1987. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. N. Engl. J. Med.
317: 415–420.PubMedCrossRefGoogle Scholar
Research and Academic Career Development Opportunities in Hematology. Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute: 1987.Google Scholar
© Plenum Press, New York 1988